Guidance for the treatment of deep vein thrombosis and pulmonary embolism
Open accessThe DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Abstract
This guidance document focuses on the diagnosis and treatment of venous thromboembolism (VTE). Efficient, cost effective diagnosis of VTE is facilitated by combining medical history and physical examination with pre-test probability models, D dimer testing and selective use of confirmatory imaging. Clinical prediction rules, biomarkers and imaging can be used to tailor therapy to disease severity. Anticoagulation options for acute VTE include unfractionated heparin, low molecular weight heparin, fondaparinux and the direct oral anticoagulants (DOACs). DOACs are as effective as conventional therapy with LMWH and vitamin K antagonists. Thrombolytic therapy is reserved for massive pulmonary embolism (PE) or extensive deep vein thrombosis (DVT). Inferior vena cava filters are reserved for patients with acute VTE and contraindications to anticoagulation. Retrievable filters are strongly preferred. The possibility of thoracic outlet syndrome and May-Thurner syndrome should be considered in patients with subclavian/axillary and left common iliac vein DVT, respectively in absence of identifiable triggers. The optimal duration of therapy is dictated by the presence of modifiable thrombotic risk factors. Long term anticoagulation should be considered in patients with unprovoked VTE as well as persistent prothrombotic risk factors such as cancer. Short-term therapy is sufficient for most patients with VTE associated with transient situational triggers such as major surgery. Biomarkers such as D dimer and risk assessment models such the Vienna risk prediction model offer the potential to customize VTE therapy for the individual patient. Insufficient data exist to support the integration of bleeding risk models into duration of therapy planning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · cited 1×
“41) [39].”
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237 · cited 4×
“7) (Table 16) [40].”
BackgroundMethodInfluential2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Self-citationDabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., & Goldhaber, S. Z. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906598 · Cited by 2,583
Büller (2012) · doi:10.1056/nejmoa1113572 · Cited by 2,353
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Masiukiewicz, U., Pak, R., Thompson, J., Raskob, G. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302507 · Cited by 2,324 · cited 1×
“Apixaban, an oral direct factor Xa inhibitor, was compared to conventional therapy (enoxaparin followed by warfarin) for treatment of VTE in the AMPLIFY study and to placebo in the AMPLIFY EXT trial [44, 45].”
MethodSelf-citationMalignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, J. W. (2005) · JAMA · doi:10.1001/jama.293.6.715 · Cited by 1,949
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
The Hokusai-VTE Investigators (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306638 · Cited by 1,869 · cited 2×
“Edoxaban was compared with warfarin in the treatment of VTE in the HOKUSAI-VTE study, a large randomized double-blind non-inferiority study conducted in 8292 patients enrolled in 439 centers in 37 countries [46].”
BackgroundMethodPrandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0108 · Cited by 1,863
Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis
Wells, P. S., Anderson, D. R., Rodger, M., Forgie, M., Kearon, C., Dreyer, J., Kovacs, G., Mitchell, M., Lewandowski, B., & Kovacs, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023153 · Cited by 1,552
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Apixaban for Extended Treatment of Venous Thromboembolism
Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Porcari, A., Raskob, G. E., & Weitz, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207541 · Cited by 1,366 · cited 3×
“Long term therapy trials with DOACs indicate that these medications will be very effective for long term therapy of VTE in patients with unprovoked VTE [40, 45, 111].”
BackgroundMethodSelf-citation2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Konstantinides, S., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M., Humbert, M., Kucher, N., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0211 · Cited by 1,349
Self-citationHeit, J. A., Kobbervig, C. E., James, A. H., Petterson, T. M., Bailey, K. R., & Melton, L. J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00006 · Cited by 1,338
Evidence-Based Management of Anticoagulant Therapy
Holbrook, A., Schulman, S., Witt, D. M., Vandvik, P. O., Fish, J., Kovacs, M. J., Svensson, P. J., Veenstra, D. L., Crowther, M., & Guyatt, G. H. (2012) · Chest · doi:10.1378/chest.11-2295 · Cited by 1,269
Self-citationValue of assessment of pretest probability of deep-vein thrombosis in clinical management
Wells, P. S., Anderson, D. R., Bormanis, J., Guy, F., Mitchell, M., Gray, L., Clement, C., Robinson, K. S., & Lewandowski, B. (1997) · The Lancet · doi:10.1016/s0140-6736(97)08140-3 · Cited by 1,229
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
Hooper, C., Laurence, I., Harvey, J., Morley, A., Darby, M., Edey, A., & Maskell, N. (2014) · Respiration · doi:10.1159/000347003 · Cited by 1,184
Garcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2291 · Cited by 1,091
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Linkins, L.-A., Dans, A. L., Moores, L. K., Bona, R., Davidson, B. L., Schulman, S., & Crowther, M. (2012) · Chest · doi:10.1378/chest.11-2303 · Cited by 1,018
Self-citationUse of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism
Wells, P. S., Ginsberg, J. S., Anderson, D. R., Kearon, C., Gent, M., Turpie, A. G., Bormanis, J., Weitz, J., Chamberlain, M., Bowie, D., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-12-199812150-00002 · Cited by 1,002
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Schellong, S., Eriksson, H., Baanstra, D., Kvamme, A. M., Friedman, J., Mismetti, P., & Goldhaber, S. Z. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1113697 · Cited by 983
Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism: The ADJUST-PE Study
Righini, M., Van Es, J., Den Exter, P. L., Roy, P.-M., Verschuren, F., Ghuysen, A., Rutschmann, O. T., Sanchez, O., Jaffrelot, M., Trinh-Duc, A., et al. (2014) · JAMA · doi:10.1001/jama.2014.2135 · Cited by 958
The PREPIC Study Group (2005) · Circulation · doi:10.1161/circulationaha.104.512834 · Cited by 931
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
Schulman, S., Kakkar, A. K., Goldhaber, S. Z., Schellong, S., Eriksson, H., Mismetti, P., Christiansen, A. V., Friedman, J., Le Maulf, F., Peter, N., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.004450 · Cited by 923
NATURAL HISTORY OF POSTOPERATIVE DEEP-VEIN THROMBOSIS
Kakkar, V. V., Howe, C. T., Flanc, C., & Clarke, M. B. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90002-6 · Cited by 899
Martel, N., Lee, J., & Wells, P. S. (2005) · Blood · doi:10.1182/blood-2005-04-1546 · Cited by 875
Brandjes, D. P., Büller, H. R., Heijboer, H., Huisman, M. V., de Rijk, M., Jagt, H., & ten Cate, J. W. (1997) · The Lancet · doi:10.1016/s0140-6736(96)12215-7 · Cited by 873
d-Dimer for the Exclusion of Acute Venous Thrombosis and Pulmonary Embolism: A Systematic Review
Stein, P. D., Hull, R. D., Patel, K. C., Olson, R. E., Ghali, W. A., Brant, R., Biel, R. K., Bharadia, V., & Kalra, N. K. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00005 · Cited by 800
Kearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Self-citationPOMP, E. R., LENSELINK, A. M., ROSENDAAL, F. R., & DOGGEN, C. J. M. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02921.x · Cited by 724
Bates, S. M., Jaeschke, R., Stevens, S. M., Goodacre, S., Wells, P. S., Stevenson, M. D., Kearon, C., Schunemann, H. J., Crowther, M., Pauker, S. G., et al. (2012) · Chest · doi:10.1378/chest.11-2299 · Cited by 686
Self-citationPrandoni, P., Lensing, A. W. A., Prins, M. H., Frulla, M., Marchiori, A., Bernardi, E., Tormene, D., Mosena, L., Pagnan, A., & Girolami, A. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-4-200408170-00004 · Cited by 659
Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M. R., Levenson, M., Sheu, T.-C., Mott, K., Goulding, M. R., Houstoun, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012061 · Cited by 644
Aspirin for Preventing the Recurrence of Venous Thromboembolism
Becattini, C., Agnelli, G., Schenone, A., Eichinger, S., Bucherini, E., Silingardi, M., Bianchi, M., Moia, M., Ageno, W., Vandelli, M. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114238 · Cited by 620
Self-citationAujesky, D., Roy, P.-M., Verschuren, F., Righini, M., Osterwalder, J., Egloff, M., Renaud, B., Verhamme, P., Stone, R. A., Legall, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60824-6 · Cited by 598
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
Agnelli, G., Prandoni, P., Santamaria, M. G., Bagatella, P., Iorio, A., Bazzan, M., Moia, M., Guazzaloca, G., Bertoldi, A., Tomasi, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450302 · Cited by 591
Self-citationThrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events
Christiansen, S. C. (2005) · JAMA · doi:10.1001/jama.293.19.2352 · Cited by 586
Rodger, M. A., Kahn, S. R., Wells, P. S., Anderson, D. A., Chagnon, I., Le Gal, G., Solymoss, S., Crowther, M., Perrier, A., White, R., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080493 · Cited by 581 · cited 1×
“They have dubbed their clinical prediction model ‘‘Men Continue and HERDOO2’’ [148].”
Self-citationThe Epidemiology of Venous Thromboembolism in the Community
Mohr, D., Petterson, T., Lohse, C., O’Fallon, W. M., Melton, L. J., Heit, J., & Silverstein, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616243 · Cited by 571
NEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSIS
LAGERSTEDT, C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90459-3 · Cited by 569
Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
Brighton, T. A., Eikelboom, J. W., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210384 · Cited by 563
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
Kahn, S. R., Shapiro, S., Wells, P. S., Rodger, M. A., Kovacs, M. J., Anderson, D. R., Tagalakis, V., Houweling, A. H., Ducruet, T., Holcroft, C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61902-9 · Cited by 524
Eichinger, S., Heinze, G., Jandeck, L. M., & Kyrle, P. A. (2010) · Circulation · doi:10.1161/circulationaha.109.925214 · Cited by 510
Self-citationSchoepf, U. J., Kucher, N., Kipfmueller, F., Quiroz, R., Costello, P., & Goldhaber, S. Z. (2004) · Circulation · doi:10.1161/01.cir.0000147612.59751.4c · Cited by 489
Carrier, M., Le Gal, G., Wells, P. S., & Rodger, M. A. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-9-201005040-00008 · Cited by 473 · cited 1×
“It is important to note that the estimates for the case fatality rate for major bleeding are based upon the initial course of anticoagulation when bleeding tends to be more frequent [114].”
BackgroundAgnelli, G., & Becattini, C. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0907731 · Cited by 444
Self-citationTOSETTO, A., IORIO, A., MARCUCCI, M., BAGLIN, T., CUSHMAN, M., EICHINGER, S., PALARETI, G., POLI, D., TAIT, R. C., & DOUKETIS, J. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04735.x · Cited by 443
Self-citationUchino, K. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.1666 · Cited by 431
Sweetland, S., Green, J., Liu, B., Berrington de Gonzalez, A., Canonico, M., Reeves, G., Beral, V., & collaborators, O. B. O. T. M. W. S. (2009) · BMJ · doi:10.1136/bmj.b4583 · Cited by 421
Pinede, L., Ninet, J., Duhaut, P., Chabaud, S., Demolombe-Rague, S., Durieu, I., Nony, P., Sanson, C., & Boissel, J.-P. (2001) · Circulation · doi:10.1161/01.cir.103.20.2453 · Cited by 408
Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism
Agnelli, G., Prandoni, P., Becattini, C., Silingardi, M., Taliani, M. R., Miccio, M., Imberti, D., Poggio, R., Ageno, W., Pogliani, E., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00008 · Cited by 400
Self-citationIorio, A., Kearon, C., Filippucci, E., Marcucci, M., Macura, A., Pengo, V., Siragusa, S., & Palareti, G. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.367 · Cited by 385 · cited 2×
“7 % per patient-year, which is less than the risk of major bleeding associated with VKA as well as direct oral anticoagulants [81].”
BackgroundHron, G., Kollars, M., Binder, B. R., Eichinger, S., & Kyrle, P. A. (2006) · JAMA · doi:10.1001/jama.296.4.397 · Cited by 381
Self-citationDahlman, T. C. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90378-v · Cited by 379
Risk Factors for Venous Thrombotic Disease
Rosendaal, F. R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615887 · Cited by 375
The Prophylactic Portacaval Shunt
(1972) · The Lancet · doi:10.1016/s0140-6736(72)91163-4 · Cited by 373
Boutitie, F., Pinede, L., Schulman, S., Agnelli, G., Raskob, G., Julian, J., Hirsh, J., & Kearon, C. (2011) · BMJ · doi:10.1136/bmj.d3036 · Cited by 371 · cited 1×
“) have not been associated with lasting reductions in recurrent VTE [15, 110].”
BackgroundSelf-citationOverweight, Obesity, and the Risk of Recurrent Venous Thromboembolism
Eichinger, S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1678 · Cited by 361
Self-citationAbraham, N. S., Singh, S., Alexander, G. C., Heien, H., Haas, L. R., Crown, W., & Shah, N. D. (2015) · BMJ · doi:10.1136/bmj.h1857 · Cited by 347
Raja, A. S., Greenberg, J. O., Qaseem, A., Denberg, T. D., Fitterman, N., Schuur, J. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2015) · Annals of Internal Medicine · doi:10.7326/m14-1772 · Cited by 340
Simplification of the Revised Geneva Score for Assessing Clinical Probability of Pulmonary Embolism
Klok, F. A., Mos, I. C. M., Nijkeuter, M., Righini, M., Perrier, A., Le Gal, G., & Huisman, M. V. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.19.2131 · Cited by 338
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10
Lidegaard, O., Nielsen, L. H., Skovlund, C. W., & Lokkegaard, E. (2012) · BMJ · doi:10.1136/bmj.e2990 · Cited by 326
Chai-Adisaksopha, C., Crowther, M., Isayama, T., & Lim, W. (2014) · Blood · doi:10.1182/blood-2014-07-590323 · Cited by 326
Self-citationCalf deep venous thrombosis. A wolf in sheep's clothing?
Philbrick, J. T. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.10.2131 · Cited by 321
Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis
Eckman, M. H., Rosand, J., Knudsen, K. A., Singer, D. E., & Greenberg, S. M. (2003) · Stroke · doi:10.1161/01.str.0000078311.18928.16 · Cited by 304
Coutance, G., Cauderlier, E., Ehtisham, J., Hamon, M., & Hamon, M. (2011) · Critical Care · doi:10.1186/cc10119 · Cited by 294
Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
Kearon, C., & Akl, E. A. (2014) · Blood · doi:10.1182/blood-2013-12-512681 · Cited by 279
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D., Tait, R. C., & Iorio, A. (2011) · BMJ · doi:10.1136/bmj.d813 · Cited by 278 · cited 1×
“If the patient favors discontinuation of anticoagulation, we use the Vienna Prediction Model or data derived from the literature to determine an estimate of the patients risk for recurrent thromboembolism so that they have a rough idea of their risk of recurrence off anticoagulation [96, 149, 151].”
MethodPettilä, V., Leinonen, P., Markkola, A., Hiilesmaa, V., & Kaaja, R. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612970 · Cited by 275
Lankeit, M., Jiménez, D., Kostrubiec, M., Dellas, C., Hasenfuss, G., Pruszczyk, P., & Konstantinides, S. (2011) · Circulation · doi:10.1161/circulationaha.111.051177 · Cited by 266
Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration
Simes, J., Becattini, C., Agnelli, G., Eikelboom, J. W., Kirby, A. C., Mister, R., Prandoni, P., & Brighton, T. A. (2014) · Circulation · doi:10.1161/circulationaha.114.008828 · Cited by 262
Self-citationCouturaud, F., Sanchez, O., Pernod, G., Mismetti, P., Jego, P., Duhamel, E., Provost, K., dit Sollier, C. B., Presles, E., Castellant, P., et al. (2015) · JAMA · doi:10.1001/jama.2015.7046 · Cited by 249 · cited 1×
“Once anticoagulation is discontinued, the risk of recurrent VTE returns [106–109].”
BackgroundWitt, D. M., Delate, T., Garcia, D. A., Clark, N. P., Hylek, E. M., Ageno, W., Dentali, F., & Crowther, M. A. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.4261 · Cited by 236
Self-citationStreiff, M. B., Bockenstedt, P. L., Cataland, S. R., Chesney, C., Eby, C., Fanikos, J., Fogarty, P. F., Gao, S., Garcia-Aguilar, J., Goldhaber, S. Z., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0062 · Cited by 235
Self-citationCARRIER, M., LE GAL, G., CHO, R., TIERNEY, S., RODGER, M., & LEE, A. Y. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03326.x · Cited by 229
Assessing bleeding risk in patients taking anticoagulants
Shoeb, M., & Fang, M. C. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0899-7 · Cited by 228
Geersing, G. J., Zuithoff, N. P. A., Kearon, C., Anderson, D. R., ten Cate-Hoek, A. J., Elf, J. L., Bates, S. M., Hoes, A. W., Kraaijenhagen, R. A., Oudega, R., et al. (2014) · BMJ · doi:10.1136/bmj.g1340 · Cited by 227
Louzada, M. L., Carrier, M., Lazo-Langner, A., Dao, V., Kovacs, M. J., Ramsay, T. O., Rodger, M. A., Zhang, J., Lee, A. Y. Y., Meyer, G., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.051920 · Cited by 227
Jiménez, D., Kopecna, D., Tapson, V., Briese, B., Schreiber, D., Lobo, J. L., Monreal, M., Aujesky, D., Sanchez, O., Meyer, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201311-2040oc · Cited by 226
Venous Thrombosis from Air Travel: The LONFLIT3 Study
Cesarone, M. R., Belcaro, G., Nicolaides, A. N., INCANDELA, L., Sanctis, M. T. D., Geroulakos, G., Lennox, A., Myers, K. A., Moia, M., IPPOLITO, E., et al. (2002) · Angiology · doi:10.1177/000331970205300101 · Cited by 222
Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage
Majeed, A., Kim, Y.-K., Roberts, R. S., Holmström, M., & Schulman, S. (2010) · Stroke · doi:10.1161/strokeaha.110.593087 · Cited by 219
Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2015) · BMJ · doi:10.1136/bmj.h2135 · Cited by 215
Risk factors for venous thrombosis – current understanding from an epidemiological point of view
Lijfering, W. M., Rosendaal, F. R., & Cannegieter, S. C. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08206.x · Cited by 214
Chee, C. E., Ashrani, A. A., Marks, R. S., Petterson, T. M., Bailey, K. R., Melton, L. J., & Heit, J. A. (2014) · Blood · doi:10.1182/blood-2014-01-549733 · Cited by 210
SWEETLAND, S., BERAL, V., BALKWILL, A., LIU, B., BENSON, V. S., CANONICO, M., GREEN, J., & REEVES, G. K. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04919.x · Cited by 208
KOVACS, M. J., KAHN, S. R., RODGER, M., ANDERSON, D. R., ANDREOU, R., MANGEL, J. E., MORROW, B., CLEMENT, A. M., & WELLS, P. S. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02613.x · Cited by 200
TRIPODI, A., LEGNANI, C., CHANTARANGKUL, V., COSMI, B., PALARETI, G., & MANNUCCI, P. M. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03018.x · Cited by 196
Castellucci, L. A., Cameron, C., Le Gal, G., Rodger, M. A., Coyle, D., Wells, P. S., Clifford, T., Gandara, E., Wells, G., & Carrier, M. (2013) · BMJ · doi:10.1136/bmj.f5133 · Cited by 193 · cited 1×
“78) [112] (Table 16).”
BESSER, M., BAGLIN, C., LUDDINGTON, R., VAN HYLCKAMA VLIEG, A., & BAGLIN, T. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03117.x · Cited by 191
Palareti, G., Cosmi, B., Legnani, C., Antonucci, E., De Micheli, V., Ghirarduzzi, A., Poli, D., Testa, S., Tosetto, A., Pengo, V., et al. (2014) · Blood · doi:10.1182/blood-2014-01-548065 · Cited by 190
Incidence and Risk Factors of Early Venous Thrombosis Associated with Permanent Pacemaker Leads
VAN ROODEN, C. J., MOLHOEK, S. G., ROSENDAAL, F. R., SCHALIJ, M. J., MEINDERS, A. E., & HUISMAN, M. V. (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.04081.x · Cited by 190
Cannegieter, S. C., Doggen, C. J. M., van Houwelingen, H. C., & Rosendaal, F. R. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030307 · Cited by 184
Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cushman, M., Eichinger, S., Palareti, G., Poli, D., Tait, R. C., & Iorio, A. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-8-201010190-00009 · Cited by 175
Self-citationShort-term natural history of isolated gastrocnemius and soleal vein thrombosis
MacDonald, P. S., Kahn, S. R., Miller, N., & Obrand, D. (2003) · Journal of Vascular Surgery · doi:10.1067/mva.2003.149 · Cited by 170
Kuipers, S., Cannegieter, S. C., Middeldorp, S., Robyn, L., Buller, H. R., & Rosendaal, F. R. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040290 · Cited by 163
Diagnosis and management of upper extremity deep-vein thrombosis in adults
Grant, J. D., Woller, S. C., Lee, E. W., Kee, S. T., Liu, D. M., Lohan, D. G., Elliott, C. G., & Stevens, S. M. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-05-0352 · Cited by 161
Kearon, C., Spencer, F. A., O’Keeffe, D., Parpia, S., Schulman, S., Baglin, T. P., Stevens, S. M., Kaatz, S., Bauer, K. A., Douketis, J. D., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1275 · Cited by 154
Self-citationCosmi, B., Legnani, C., Tosetto, A., Pengo, V., Ghirarduzzi, A., Testa, S., Prisco, D., Poli, D., Tripodi, A., Marongiu, F., et al. (2009) · Blood · doi:10.1182/blood-2009-08-237354 · Cited by 150
Outpatient treatment of symptomatic pulmonary embolism: A systematic review and meta-analysis
Piran, S., Gal, G. L., Wells, P. S., Gándara, E., Righini, M., Rodger, M. A., & Carrier, M. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.08.012 · Cited by 144
Evolving use of new oral anticoagulants for treatment of venous thromboembolism
Yeh, C. H., Gross, P. L., & Weitz, J. I. (2014) · Blood · doi:10.1182/blood-2014-03-563056 · Cited by 137
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Middeldorp, S., Prins, M. H., & Hutten, B. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001367.pub3 · Cited by 133
Owens, C. A., Bui, J. T., Knuttinen, M. G., Gaba, R. C., & Carrillo, T. C. (2010) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2010.02.021 · Cited by 130
Physical activity in patients with deep venous thrombosis: A systematic review
Kahn, S. R., Shrier, I., & Kearon, C. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.10.011 · Cited by 127
Cosmi, B., Lessiani, G., Rodorigo, G., Guazzaloca, G., Brusi, C., Valdré, L., Conti, E., Sartori, M., Legnani, C., & Palareti, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-06-0351 · Cited by 126
Schulman, S., Zondag, M., Linkins, L., Pasca, S., Cheung, Y. W., de Sancho, M., Gallus, A. S., Lecumberri, R., Molnar, S., Ageno, W., et al. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12955 · Cited by 113
Ageno, W., Antonucci, E., Cosmi, B., Kovacs, M. J., Gal, G. L., Ockelford, P., Poli, D., Prandoni, P., Rodger, M., Saccullo, G., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-04-0336 · Cited by 111
Trujillo‐Santos, J., den Exter, P. L., Gómez, V., del Castillo, H., Moreno, C., van der Hulle, T., Huisman, M. V., Monréal, M., Yusen, R. D., & Jiménez, D. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12393 · Cited by 111
Rodger, M. A., Kahn, S. R., Cranney, A., Hodsman, A. B., Kovacs, M. J., Clement, A. M., Lazo‐Langner, A., & Hague, W. M. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02634.x · Cited by 98
Ageno, W., Squizzato, A., Wells, P. S., Buller, H. R., & Johnson, G. E. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12301 · Cited by 96
van Lennep, J. E. R., MEIJER, E., Klumper, F. J. C. M., MIDDELDORP, J. M., Bloemenkamp, K. W. M., & Middeldorp, S. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04186.x · Cited by 96
Kline, J. A., Webb, W. B., Jones, A. E., & Hernandez‐Nino, J. (2004) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.03.018 · Cited by 89
Cushman, M., Glynn, R. J., Goldhaber, S. Z., Moll, S., Bauer, K. A., Deitcher, S. R., SHRIVASTAVA, S., & Ridker, P. M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02140.x · Cited by 85
Self-citationAndras, A., Tenna, A. S., & Crawford, F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002001.pub2 · Cited by 84
Risk stratification of normotensive patients with acute symptomatic pulmonary embolism
Jiménez, D., Aujesky, D., & Yusen, R. D. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08406.x · Cited by 82
Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism
White, R. H. R., Chan, W., Zhou, H., & Ginsberg, J. S. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-04-0238 · Cited by 80
Luk, C., Wells, P. S., Anderson, D. R., & Kovacs, M. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00840-3 · Cited by 78
Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time
Hron, G., Eichinger, S., Weltermann, A., Quehenberger, P., Halbmayer, W. M., & Kyrle, P. A. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01868.x · Cited by 78
Self-citationThe Anticoagulation of Calf Thrombosis (ACT) Project
Horner, D. E., Hogg, K. E., Body, R., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0235 · Cited by 75
Calf deep vein thrombosis—A wolf in sheep's clothing?
Turnipseed, W. D. (1989) · Journal of Vascular Surgery · doi:10.1016/0741-5214(89)90169-9 · Cited by 74
Crobach, M. J. T., Dolsma, A., Donker, M. L., Eijsvogel, M., Faber, L. M., Hofstee, H. M. A., Kaasjager, K. A. H., Kruip, M. J. H. A., Labots, G., Melissant, C. F., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-07-0466 · Cited by 72
Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study
Poli, D., Antonucci, E., Dentali, F., Erba, N., Testa, S., Tiraferri, E., & Palareti, G. (2014) · Neurology · doi:10.1212/wnl.0000000000000245 · Cited by 72
Validation of a diagnostic approach to exclude recurrent venous thromboembolism
Gal, G. L., Kovacs, M. J., Carrier, M., Do, K., Kahn, S. R., Wells, P. S., Anderson, D. R., Chagnon, I., Solymoss, S., Crowther, M. A., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03324.x · Cited by 70
Self-citationLoke, Y. K., Pradhan, S., Yeong, J. K.-Y., & Kwok, C. S. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12376 · Cited by 63
Limone, B. L., Hernández, A. V., Michalak, D., Bookhart, B., & Coleman, C. I. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.08.003 · Cited by 63
Eischer, L., Eichinger, S., & Kyrle, P. A. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12528 · Cited by 62
Self-citationHow I treat pregnancy-related venous thromboembolism
Middeldorp, S. (2011) · Blood · doi:10.1182/blood-2011-04-306589 · Cited by 62
Venous thromboembolism associated with pregnancy and hormonal therapy
Jacobsen, A. F., & Sandset, P. M. (2012) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2012.07.006 · Cited by 58
Vena cava filters for management of venous thromboembolism: A clinical review
Rajasekhar, A., & Streiff, M. B. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.07.001 · Cited by 58
Self-citationShapiro, S., Ducruet, T., Wells, P. S., Rodger, M. A., Kovacs, M. J., Anderson, D. R., Tagalakis, V., Morrison, D., Solymoss, S., Miron, M. ‐., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-05-0430 · Cited by 54
Legnani, C., Cini, M., Guazzaloca, G., Palareti, G., & Cosmi, B. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-08-0559 · Cited by 53
Spencer, F. A., Kroll, A., Lessard, D., et al. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0670-x · Cited by 46
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Hutten, B., & Prins, M. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001367 · Cited by 43
Pregnancy-Associated Venous Thromboembolism: Prevention and Treatment
Bates, S. M. (2011) · Seminars in Hematology · doi:10.1053/j.seminhematol.2011.08.003 · Cited by 40
Boutitie, F., Pinède, L., & Schulman, S. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.08.030 · Cited by 38
Predicting the risk of recurrent venous thromboembolism (VTE)
Streiff, M. B. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1188-4 · Cited by 32
Self-citationMismetti, P. (2008) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2008.09.011 · Cited by 20
Fondaparinux in the initial and long-term treatment of venous thromboembolism
Pesavento, R., Amitrano, M., Trujillo‐Santos, J., Micco, P. D., Mangiacapra, S., López‐Jiménez, L., Falgà-Tirado, C., Garcia-Bragado, F., Piovella, C., Prandoni, P., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.11.032 · Cited by 18
Thachil, J. V. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013519753 · Cited by 3
Cited by
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
Stevens, S. M., Woller, S. C., Baumann Kreuziger, L., Bounameaux, H., Doerschug, K., Geersing, G.-J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., et al. (2021) · Chest · doi:10.1016/j.chest.2021.07.056 · Cited by 416
Deep vein thrombosis: pathogenesis, diagnosis, and medical management
Stone, J., Hangge, P., Albadawi, H., Wallace, A., Shamoun, F., Knuttien, M. G., Naidu, S., & Oklu, R. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.09.01 · Cited by 381
How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy
Schulman, S. (2017) · Blood · doi:10.1182/blood-2017-03-742304 · Cited by 62
Metadata
- Authors
- Streiff, M. B., Agnelli, G., Connors, J. M., Crowther, M., Eichinger, S., Lopes, R., McBane, R. D., Moll, S., & Ansell, J.
- Venue
- Journal of Thrombosis and Thrombolysis
- Published
- 2016-01
- Volume
- 41
- Issue
- 1
- Pages
- 32-67
- ISSN
- 0929-5305 (ISSN-L)
- 1573-742X
- OpenAlex
- W2284149813
- Cited by
- 344
- References
- 140
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.